Phibro Animal Health (PAHC) Stock Statistics & Valuation Metrics

Phibro Animal Health has a market cap or net worth of $1.44B. The enterprise value is $2.17B.

Market Cap

$1.44B

Enterprise Value

$2.17B

Phibro Animal Health has 21,105,570 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

21,105,570

Owned by Insiders

1.18%

Owned by Institutions

90.06%

Phibro Animal Health’s return on equity (ROE) is 0.26 and return on invested capital (ROIC) is 11.81%.

Return on Equity (ROE)

0.26

Return on Assets (ROA)

0.07

Return on Invested Capital (ROIC)

11.81%

Return on Capital Employed (ROCE)

0.17

Revenue Per Employee

582.76K

Profits Per Employee

38.28K

Employee Count

2,605

Asset Turnover

1.01

Inventory Turnover

1.88

The current PE Ratio of Phibro Animal Health is 14.16. Phibro Animal Health’s PEG ratio is 0.27.

PE Ratio

14.16

PS Ratio

0.95

PB Ratio

3.50

Price to FCF

67.39

Price to Operating Cash Flow

17.03

PEG Ratio

0.27

In the last 12 months, Phibro Animal Health had revenue of 1.52B and earned 99.72M in profits. Earnings per share was 2.46.

Revenue

1.52B

Gross Profit

511.71M

Operating Income

198.44M

Pretax Income

137.35M

Net Income

99.72M

EBITDA

236.46M

Earnings Per Share (EPS)

2.46

In the last 12 months, operating cash flow was 85.73M and capital expenditures -64.06M, giving a free cash flow of 21.67M billion.

Operating Cash Flow

85.73M

Free Cash Flow

21.67M

Free Cash Flow per Share

0.53

Phibro Animal Health pays an annual dividend of $0.12, resulting in a dividend yield of 1.33%

Dividend Per Share

$0.12

Dividend Yield

1.33%

Payout Ratio

16.38%

Free Cash Flow Yield

1.48%

Earnings Yield

7.04%

Beta

0.70

52-Week Price Change

-19.53%

50-Day Moving Average

36.79

200-Day Moving Average

40.83

Relative Strength Index (RSI)

46.53

Average Volume (3m)

232.44K

Phibro Animal Health upcoming earnings date is Feb 10, 2027, TBA (Not Confirmed).

Last Earnings Date

Nov 04, 2026

Next Earnings Date

Feb 10, 2027

Ex-Dividend Date

Jun 03, 2026

Phibro Animal Health as a current ratio of 2.96, with Debt / Equity ratio of 204.62%

Current Ratio

2.96

Quick Ratio

1.27

Debt to Market Cap

0.57

Net Debt to EBITDA

3.08

Interest Coverage Ratio

4.17

In the past 12 months, Phibro Animal Health has paid 37.63M in taxes.

Income Tax

37.63M

Effective Tax Rate

0.27

Phibro Animal Health EV to EBITDA ratio is 9.15, with an EV/FCF ratio of 100.32.

EV to Sales

1.41

EV to EBITDA

9.15

EV to Free Cash Flow

100.32

EV to Operating Cash Flow

25.36

Phibro Animal Health has $83.12M in cash and marketable securities with $789.13M in debt, giving a net cash position of -$706.00M billion.

Cash & Marketable Securities

$83.12M

Total Debt

$789.13M

Net Cash

-$706.00M

Net Cash Per Share

-$33.45

Tangible Book Value Per Share

$8.11

Gross margin is 33.78%, with operating margin of 12.99%, and net profit margin of 6.67%.

Gross Margin

33.78%

Operating Margin

12.99%

Pretax Margin

9.08%

Net Profit Margin

6.67%

EBITDA Margin

15.41%

EBIT Margin

12.02%

The average price target for Phibro Animal Health is $45.00, which is 11.43% higher than the current price. The consensus rating is Neutral

Price Target

$45.00

Price Target Upside

25.10% Upside

Analyst Consensus

Neutral

Analyst Count

2

Revenue Growth Forecast

10.10%

EPS Growth Forecast

51.28%

Smart Score

4

AI Score

60